机构:[1]Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.[2]School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, Guangdong, China.[3]Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
This work was supported by grants from the National Natural Science Foundation of China (82202877 and 82073162), China Postdoctoral Science Foundation (2023M731561), Natural Science Foundation of Guangdong Province of
China (2021A1515010762), Present Foundation of Nanfang Hospital, Southern
Medical University (2021C002 and 2020Z005).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|1 区医学
小类|1 区生化与分子生物学1 区肿瘤学
最新[2025]版:
大类|1 区医学
小类|1 区生化与分子生物学1 区肿瘤学
第一作者:
第一作者机构:[1]Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Zheng Zaosong,Zeng Xiangbo,Zhu Yuanchao,et al.CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p/CYP1B1 axis[J].Molecular Cancer.2024,23(1):4.doi:10.1186/s12943-023-01912-w.
APA:
Zheng Zaosong,Zeng Xiangbo,Zhu Yuanchao,Leng Mengxin,Zhang Zhiyong...&Tan Wanlong.(2024).CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p/CYP1B1 axis.Molecular Cancer,23,(1)
MLA:
Zheng Zaosong,et al."CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p/CYP1B1 axis".Molecular Cancer 23..1(2024):4